<sup>153</sup>Sm-EDTMP治疗前列腺癌内分泌治疗后骨转移骨痛的效果评价

汤召兵; 陈在贤; 刘朝东; 刘航; 王德林

您当前的位置：

首页 >

文章列表页 >

¹⁵³Sm-EDTMP治疗前列腺癌内分泌治疗后骨转移骨痛的效果评价

更新时间：2024-01-17

- ¹⁵³Sm-EDTMP治疗前列腺癌内分泌治疗后骨转移骨痛的效果评价
- Evaluation of ¹⁵³Sm-EDTMP Therapy for Metastasis Prostate Cancer and Pain due to Bony Metastases after Hormone Therapy
- 重庆医科大学学报 2006年第3期页码：417-418
- 作者机构：
  
  1. 重庆医科大学附属第一医院泌尿外科
  2. 重庆医科大学附属第一医院泌尿外科,重庆,400016
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R737.25
- 纸质出版日期：2006，
扫描看全文
[1]汤召兵,陈在贤,刘朝东,刘航,王德林.~(153)Sm-EDTMP治疗前列腺癌内分泌治疗后骨转移骨痛的效果评价[J].重庆医科大学学报,2006(03):417-418+421.

TANG Zhaobing, et al. Evaluation of ¹⁵³Sm-EDTMP Therapy for Metastasis Prostate Cancer and Pain due to Bony Metastases after Hormone Therapy[J]. Journal of Chongqing Medical University, 2006,(3):417-418.
[1]汤召兵,陈在贤,刘朝东,刘航,王德林.~(153)Sm-EDTMP治疗前列腺癌内分泌治疗后骨转移骨痛的效果评价[J].重庆医科大学学报,2006(03):417-418+421. DOI：

TANG Zhaobing, et al. Evaluation of ¹⁵³Sm-EDTMP Therapy for Metastasis Prostate Cancer and Pain due to Bony Metastases after Hormone Therapy[J]. Journal of Chongqing Medical University, 2006,(3):417-418. DOI：

摘要

目的:评价153Sm-EDTMP（153钐-乙二胺四甲撑膦酸）对前列腺癌患者行内分泌治疗后骨转移灶骨痛的治疗效果。方法:选择18例前列腺癌已行双侧睾丸切除术+口服福至尔治疗3～6个月、骨转移灶及骨痛未缓解患者

用153Sm-EDTMP治疗

153Sm-EDTMP用量为37MBq/kg体重.次

1次/月×（3～6）个月。密切观察骨痛缓解情况

治疗3个月后行骨扫描了解骨转移灶情况。结果:18例患者中14例骨痛有不同程度缓解

占77.8%

骨扫描示骨转移灶客观反应率为55.5%（10/18）。结论:对晚期前列腺癌、在行内分泌治疗后存在骨转移顽固性骨痛患者

153Sm-EDTMP内放射治疗仍有较好效果。

Abstract

Objective: To evaluate the effect of Samarium etramthylene phosphoric acid(153Sm-EDTMP) in the treatment of painful bony metastases from prostate cancer after hormone therapy.Methods: 18 patients after being treated with hormone therapy(excision of testes+flutamide) for 3~6 months and with painful bony metastases from prostate cancer were injected 153Sm-EDTMP(dosage:37MBq/kg)

After the patients underwent 1~3 dose treatment.The palliation of pain and change of bone metastases on bone scans were evaluated.Results: A significant decrease of bone pain was achieved

making up 77.8%(14/18) and X ray and bone radionuclide imaging exam showed that 2 patients achieved complete focus disappearance

and 8 patients achieved partial focus disappearance.The response rate is 55.5%.Conclusion: 153Sm-EDTMP radiotherapy is efficacious to the refractory painful bone metastases in prostate cancer.

关键词

前列腺癌骨转移骨痛153Sm-EDTMP内分泌治疗

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

乳腺癌骨转移影响因素探讨

MACS方法分选CD133 /CD44 前列腺癌干细胞的初步鉴定

153Sm-EDTMP治疗前列腺癌内分泌治疗后骨转移骨痛的效果评价

Evaluation of 153Sm-EDTMP Therapy for Metastasis Prostate Cancer and Pain due to Bony Metastases after Hormone Therapy

DOI：

摘要

Abstract

关键词

Keywords

references

¹⁵³Sm-EDTMP治疗前列腺癌内分泌治疗后骨转移骨痛的效果评价

Evaluation of ¹⁵³Sm-EDTMP Therapy for Metastasis Prostate Cancer and Pain due to Bony Metastases after Hormone Therapy